SARS-CoV-2 Mpro-IN-9

Modify Date: 2024-01-13 23:20:04

SARS-CoV-2 Mpro-IN-9 Structure
SARS-CoV-2 Mpro-IN-9 structure
Common Name SARS-CoV-2 Mpro-IN-9
CAS Number 2754370-99-3 Molecular Weight 346.34
Density N/A Boiling Point N/A
Molecular Formula C20H14N2O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-2 Mpro-IN-9


SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM)[1].

 Names

Name SARS-CoV-2 Mpro-IN-9

 SARS-CoV-2 Mpro-IN-9 Biological Activity

Description SARS-CoV-2 Mpro-IN-9 (compound c7) is a nonpeptidic, noncovalent SARS-CoV-2 Mpro inhibitor (IC50=0.085 μM), with improved physicochemical and drug metabolism and pharmacokinetics (DMPK) properties. SARS-CoV-2 Mpro-IN-9 inhibits viral replication (EC50=1.10 μM) in SARS-CoV-2-infected Vero E6 cells, while exhibits low cytotoxic effects (CC50>50 μM)[1].
Related Catalog
Target

IC50: 0.085 μM (SARS-CoV-2), EC50: 1.10 μM (viral replication)[1]

References

[1]. Zhang K, et al. Discovery of quinazolin-4-one-based non-covalent inhibitors targeting the severe acute respiratory syndrome coronavirus 2 main protease (SARS-CoV-2 Mpro). Eur J Med Chem. 2023 Sep 5;257:115487.  

 Chemical & Physical Properties

Molecular Formula C20H14N2O4
Molecular Weight 346.34